Malaria HRP2-pLDH is an enzyme-linked protein antigen rapid test kit for the detection of Plasmodium falciparum parasite antigens in human plasma. This unique test utilizes a proprietary protocol to amplify the antibodies produced by the parasite, allowing for accurate and reliable results.
The test procedure involves mixing patient serum samples with pre-coated strips containing purified HRP2-pLDH antigen, followed by incubation at room temperature for 30 minutes. The resulting reaction mixture is then analyzed using a highly sensitive colorimetric system to produce a visible signal that indicates the presence of malaria antigens.
With its high accuracy and sensitivity, this rapid test kit enables healthcare providers to quickly identify individuals infected with Plasmodium falciparum in resource-limited settings or during outbreaks. The test can be used for both early diagnosis and confirmation of infection.
The 20-test total capacity allows for the simultaneous testing of multiple patients, making it an ideal solution for clinical laboratories, public health organizations, and research institutions seeking to improve malaria diagnosis and treatment.
